Etanercept

This classification denotes an immunosuppressant with the molecular formula C2224H3475N621O698S36, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OP401G7OJC, more generally known as etanercept. European Medicines Agency schedules etanercept in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01984MIG. The term ETANERCEPT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, list 43. Most nations, for tariff and trade purposes, schedule Etanercept under HS 30021095 and SITC 54163. SMILES:. As of Q4 2014, ETANERCEPT remains US FDA's Preferred Term for this commodity. . Etanercept bears US NLM identifiers UMLS ID C0717758 and NCI Concept Code C2381.